IRB Study Number 19-794
Status Recruiting
Phase Phase 2
Location Cleveland Clinic Main Campus
Institute Heart and Vascular Institute
Description
The purpose of this study is to see if the Gore Excluder Thoracoabdominal Branch Endoprosthesis is a safe and effective treatment for the type of aneurysm you have. The Gore Excluder Thoracoabdominal Branch Endoprosthesis is an investigational (experimental) device. It is not approved by the Food and Drug Administration (FDA). You will be asked to return for 8 follow-up visits.Your participation in the research will last about 5 years.
Inclusion Criteria
Aortic aneurysm involving the visceral vessel(s) requiring treatment;
Aortic aneurysm that involves the abdominal aorta;
Age ≥ 19 years at the time of informed consent signature
Exclusion Criteria
Prior open, aortic surgery of the ascending aorta or aortic arch;
Ruptured or leaking aortic aneurysm;
Life expectancy <2 years
